JoVE Logo
Faculty Resource Center

Sign In

Recombinant Collagen I Peptide Microcarriers for Cell Expansion and Their Potential Use As Cell Delivery System in a Bioreactor Model

DOI :

10.3791/57363-v

February 7th, 2018

February 7th, 2018

7,388 Views

1Department Tissue Engineering and Regenerative Medicine, University Hospital Wuerzburg, 2Translational Center Regenerative Therapies (TLC-RT), Fraunhofer Institute for Silicate Research ISC, 3Fujifilm Manufacturing Europe B.V.

We propose a cell expansion protocol on macroporous microcarriers and their use as delivery system in a perfusion bioreactor to seed a decellularized tissue matrix. We also include different techniques to determine cell proliferation and viability of cells cultured on microcarriers. Furthermore, we demonstrate functionality of cells after bioreactor cultures.

Tags

Recombinant Collagen I Peptide Microcarriers

-- Views

Related Videos

article

Organotypic Collagen I Assay: A Malleable Platform to Assess Cell Behaviour in a 3-Dimensional Context

article

Rotating Cell Culture Systems for Human Cell Culture: Human Trophoblast Cells as a Model

article

Constructing a Collagen Hydrogel for the Delivery of Stem Cell-loaded Chitosan Microspheres

article

Skin Tattooing As A Novel Approach For DNA Vaccine Delivery

article

Microfluidic Picoliter Bioreactor for Microbial Single-cell Analysis: Fabrication, System Setup, and Operation

article

Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform

article

An Improved Method for the Preparation of Type I Collagen From Skin

article

Cultivation of Mammalian Cells Using a Single-use Pneumatic Bioreactor System

article

Minced Tissue in Compressed Collagen: A Cell-containing Biotransplant for Single-staged Reconstructive Repair

article

Fabrication of Extracellular Matrix-derived Foams and Microcarriers as Tissue-specific Cell Culture and Delivery Platforms

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved